Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marco Krasselt & Christoph Baerwald. (2014) The current relevance and use of prednisone in rheumatoid arthritis. Expert Review of Clinical Immunology 10:5, pages 557-571.
Read now
Read now
C. Book, M. Karlsson, K. Åkesson & L. Jacobsson. (2008) Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scandinavian Journal of Rheumatology 37:4, pages 248-254.
Read now
Read now
Articles from other publishers (15)
Lisa Theander, Minna Willim, Jan Åke Nilsson, Magnus Karlsson, Kristina E Åkesson, Lennart T H Jacobsson & Carl Turesson. (2020) Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis. RMD Open 6:1, pages e001142.
Crossref
Crossref
Ingiäld Hafström, Sofia Ajeganova, Kristina Forslind & Björn Svensson. (2019) Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Gulzhan Gabdulina, Melody Kasher, Aliya Beissebayeva, Dana Mussabaeva, Alexander Tokarev, Gulmira Mominova, Gulnar Essirkepova, Ainash Amanzholova, Korlan Zaurbekova, Maira Saparbaeva, Maira Bizhanova, Moldir Kulshymanova & Gregory Livshits. (2018) An epidemiological analysis of osteoporotic characteristics in patients affected with rheumatoid arthritis in Kazakhstan. Archives of Osteoporosis 13:1.
Crossref
Crossref
Serena Bugatti, Laura Bogliolo, Barbara Vitolo, Antonio Manzo, Carlomaurizio Montecucco & Roberto Caporali. (2016) Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Marlies C van der Goes, Johannes W Jacobs & Johannes W Bijlsma. (2014) The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects. Arthritis Research & Therapy 16:Suppl 2, pages S2.
Crossref
Crossref
N Duru, M C van der Goes, J W G Jacobs, T Andrews, M Boers, F Buttgereit, N Caeyers, M Cutolo, S Halliday, J A P Da Silva, J R Kirwan, D Ray, J Rovensky, G Severijns, R Westhovens & J W J Bijlsma. (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases 72:12, pages 1905-1913.
Crossref
Crossref
M. C. van der Goes, J. W. G. Jacobs, M. S. Jurgens, M. F. Bakker, M. J. van der Veen, J. H. van der Werf, P. M. J. Welsing & J. W. J. Bijlsma. (2012) Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?. Osteoporosis International 24:4, pages 1429-1436.
Crossref
Crossref
Hanh-Hung Dao, Quan-Trung Do & Junichi Sakamoto. (2011) Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis. Clinical Rheumatology 30:10, pages 1353-1361.
Crossref
Crossref
H. Franck, J. Braun, F. Buttgereit, W. Demary, G. Hein, J. Kekow, G. Schett & P.M. Kern. (2009) Knochendichtemessungen bei entzündlich-rheumatischen ErkrankungenBone densitometry in inflammatory rheumatic diseases. Zeitschrift für Rheumatologie 68:10, pages 845-850.
Crossref
Crossref
Sandeep JAIN, Vinod RAVINDRAN & Dinesh Swarup MATHUR. (2008) Detection of low bone mass using quantitative ultrasound measurements at calcaneus: comparative study of an Indian rheumatoid arthritis cohort. International Journal of Rheumatic Diseases 11:4, pages 414-420.
Crossref
Crossref
Santos Castañeda, Isidoro González-Álvaro, Francisco Rodríguez-Salvanés, María Luisa Quintana, Armando Laffon & J. Alberto García-Vadillo. (2007) Reproducibility of Metacarpophalangeal Bone Mass Measurements Obtained by Dual-Energy X-Ray Absorptiometry in Healthy Volunteers and Patients With Early Arthritis. Journal of Clinical Densitometry 10:3, pages 298-305.
Crossref
Crossref
Björn Svensson, Annelies Boonen, Kristina Albertsson, Désirée van der Heijde, Catharina Keller & Ingiäld Hafström. (2005) Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial. Arthritis & Rheumatism 52:11, pages 3360-3370.
Crossref
Crossref
Ali Bicer, Umit Tursen, Tamer Irfan Kaya, Caner Ozer, Handan Camdeviren, Guliz Ikizoglu & Canan Erdogan. (2003) Bone mineral density in patients with Beh�et?s disease. Rheumatology International 24:6, pages 355-358.
Crossref
Crossref
Raphaela Goldbach-ManskyPeter E. Lipsky. (2003) New Concepts in the Treatment of Rheumatoid Arthritis. Annual Review of Medicine 54:1, pages 197-216.
Crossref
Crossref
Qian Kang. 2002. Orthopaedic Issues in Osteoporosis. Orthopaedic Issues in Osteoporosis
483
497
.